NCT04753632

Brief Summary

COVID-19, as well as the collateral situations that it entails, has been causing panic, anguish and anxiety that has generated biopsychosocial problems in society affecting not only the physical and social level but also the mental health and well-being. The main objective of this research project is to assess the biopsychosocial status of people with cerebral palsy and related diseases and their caregivers during the COVID-19 pandemic.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 12, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 15, 2021

Completed
22 days until next milestone

Study Start

First participant enrolled

March 9, 2021

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2021

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2021

Completed
Last Updated

March 26, 2021

Status Verified

March 1, 2021

Enrollment Period

2 months

First QC Date

February 12, 2021

Last Update Submit

March 25, 2021

Conditions

Outcome Measures

Primary Outcomes (9)

  • Questionnaire of Knowledge, attitudes and practice towards COVID-19

    Questionnaire to evaluate the knowledge about COVID-19. It includes 12 items. Patients have to answer true/false. Higher puntuation indicates better knowledge results.

    Baseline

  • Caregiver COVID-19 limitation scale

    This scale is used to examine the impact of the COVID-19 pandemic on caregivers. Scores ranged from 1 to 10, and a higher score indicates more limitations.

    Baseline

  • Fear of Coronavirus-19 Scale

    It is a scale that assesses the fear of COVID-19. It consists of 7 items scored on a 5-item Likert scale. The higher the score, the more fear.

    Baseline

  • Covid-19 Stress Scale (CSS)

    COVID stress scale (CSS): is a 36-item COVID Stress Scale (CSS) to measure these features, as they pertain to COVID-19. The CSS were developed to better understand and assess COVID-19-related distress. The scales were intentionally designed so they could be readily adapted for future pandemics.

    Baseline

  • Coronavirus Anxiety Scale (CAS)

    Coronavirus anxiety scale (CAS): It is a scale that measures the anxiety generated by COVID-19 in the last two weeks. It presents 5 items and a score\> 9 indicates dysfunctional anxiety associated with the pandemic.

    Baseline

  • Connor-Davidson Resilience Scale-10

    Connor-Davidson Resilience Scale (CD-RISC) was used to measure resilience. Respondents are asked to answer on a five-point Likert scale (0 = totally disagree to 4 = totally agree)

    Baseline

  • COPE

    The Brief-COPE is a 28 item self-report questionnaire designed to measure effective and ineffective ways to cope with a stressful life event. "Coping" is defined broadly as an effort used to minimize distress associated with negative life experiences

    Baseline

  • Medical Outcomes Study-Social Support Survey

    This brief, self-administered Social Support Survey instrument was developed for patients in the Medical Outcomes Study (MOS), a two-year study of patients with chronic conditions. Higher puntuations indicate higher social support.

    Baseline

  • Zarit Burden Inventory

    The Zarit Burden Inventory examines burden associated with functional/behavioural impairments and the home care situation. Higher puntuations indicate higher burden.

    Baseline

Secondary Outcomes (7)

  • Euroqol-5D

    Baseline

  • Hospital Anxiety and Depression Scale

    Baseline

  • Pittsburgh Sleep Quality Index

    Baseline

  • International Physical Activity Questionnaire

    Baseline

  • Functional independence measure

    Baseline

  • +2 more secondary outcomes

Study Arms (2)

Cerebral palsy patients and caregivers

Cerebral palsy patients and caregivers

Healthy people and their caregivers

Healthy people and their caregivers

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Cerebral palsy patients and their caregivers

You may qualify if:

  • Cerebral palsy patients and their caregivers

You may not qualify if:

  • Patients or caregivers with Cognitive impairment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Physical Therapy

Granada, 18016, Spain

RECRUITING

MeSH Terms

Conditions

Cerebral Palsy

Condition Hierarchy (Ancestors)

Brain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator; PT; PhD

Study Record Dates

First Submitted

February 12, 2021

First Posted

February 15, 2021

Study Start

March 9, 2021

Primary Completion

May 15, 2021

Study Completion

June 15, 2021

Last Updated

March 26, 2021

Record last verified: 2021-03

Data Sharing

IPD Sharing
Will not share

Locations